Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FZL02
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,849
Award facts
- Contract value 100% obligated
- $6,848.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $6,848.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL auto-injectors. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a discrete purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $499,999,999 through the SPE2DB program. No set-aside designation was applied to this award.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company's robust contract portfolio with DLA demonstrates its consistent capability to deliver specialized pharmaceutical products, including auto-injectors and specialty medications, supporting military health system requirements. This delivery order for Xolair auto-injectors exemplifies the vendor's role in supplying essential pharmaceutical products to support DoD healthcare operations across its global footprint.
Quick answers
Who was awarded contract SPE2DB25FZL02?
SPE2DB25FZL02 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FZL02 worth?
The government has obligated $6,849 on SPE2DB25FZL02.
Is contract SPE2DB25FZL02 an order under another contract?
Yes. SPE2DB25FZL02 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZL02 competed?
The extent of competition for SPE2DB25FZL02 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award